4-phenyl substituted tetrahydroisoquinolines and use thereof
US7163949B1 · kind B1 · utility
17Cited by
15References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2000 |
| Grant date | Jan 16, 2007 |
| Priority date | — |
| Expiry date | Feb 28, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/24
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formulae IA–IF. These compounds are tetrahydroisoquinolines of the following structure:wherein R1–R8 for compounds of each of the formulae IA, IB, IC, ID, IE and IF are as described herein. Said compounds are particularly useful in the treatment of various neurological and psychiatric disorders, e.g., ADHD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.